TheStar.com - Loblaws settles hepatitis lawsuit

The proposed deal is worth $150 to anyone who received a hepatitis A vaccine, or consulted their doctor, as a precaution after public health officials disclosed the employee's condition to the public. It could cost Loblaws and its insurers at least $3 million.